SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Henriksson Karin) ;pers:(Nygren Peter)"

Sökning: WFRF:(Henriksson Karin) > Nygren Peter

  • Resultat 1-2 av 2
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Demmelmaier, Ingrid, 1960-, et al. (författare)
  • Does exercise intensity matter for fatigue during (neo-)adjuvant cancer treatment? The Phys-Can randomized clinical trial
  • 2021
  • Ingår i: Scandinavian Journal of Medicine and Science in Sports. - : Wiley. - 0905-7188 .- 1600-0838. ; 31:5, s. 1144-1159
  • Tidskriftsartikel (refereegranskat)abstract
    • Exercise during cancer treatment improves cancer-related fatigue (CRF), but the importance of exercise intensity for CRF is unclear. We compared the effects of high- vs low-to-moderate-intensity exercise with or without additional behavior change support (BCS) on CRF in patients undergoing (neo-)adjuvant cancer treatment. This was a multicenter, 2x2 factorial design randomized controlled trial (Clinical Trials NCT02473003) in Sweden. Participants recently diagnosed with breast (n = 457), prostate (n = 97) or colorectal (n = 23) cancer undergoing (neo-)adjuvant treatment were randomized to high intensity (n = 144), low-to-moderate intensity (n = 144), high intensity with BCS (n = 144) or low-to-moderate intensity with BCS (n = 145). The 6-month exercise intervention included supervised resistance training and home-based endurance training. CRF was assessed by Multidimensional Fatigue Inventory (MFI, five subscales score range 4-20), and Functional Assessment of Chronic Illness Therapy-Fatigue scale (FACIT-F, score range 0-52). Multiple linear regression for main factorial effects was performed according to intention-to-treat, with post-intervention CRF as primary endpoint. Overall, 577 participants (mean age 58.7 years) were randomized. Participants randomized to high- vs low-to-moderate-intensity exercise had lower physical fatigue (MFI Physical Fatigue subscale; mean difference −1.05 [95% CI: −1.85, −0.25]), but the difference was not clinically important (ie <2). We found no differences in other CRF dimensions and no effect of additional BCS. There were few minor adverse events. For CRF, patients undergoing (neo-)adjuvant treatment for breast, prostate or colorectal cancer can safely exercise at high- or low-to-moderate intensity, according to their own preferences. Additional BCS does not provide extra benefit for CRF in supervised, well-controlled exercise interventions.
  •  
2.
  • Glimelius, Bengt, et al. (författare)
  • U-CAN : a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.
  • 2018
  • Ingår i: Acta Oncologica. - : Taylor & Francis. - 0284-186X .- 1651-226X. ; 57:2, s. 187-194
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Progress in cancer biomarker discovery is dependent on access to high-quality biological materials and high-resolution clinical data from the same cases. To overcome current limitations, a systematic prospective longitudinal sampling of multidisciplinary clinical data, blood and tissue from cancer patients was therefore initiated in 2010 by Uppsala and Umeå Universities and involving their corresponding University Hospitals, which are referral centers for one third of the Swedish population.Material and Methods: Patients with cancer of selected types who are treated at one of the participating hospitals are eligible for inclusion. The healthcare-integrated sampling scheme encompasses clinical data, questionnaires, blood, fresh frozen and formalin-fixed paraffin-embedded tissue specimens, diagnostic slides and radiology bioimaging data.Results: In this ongoing effort, 12,265 patients with brain tumors, breast cancers, colorectal cancers, gynecological cancers, hematological malignancies, lung cancers, neuroendocrine tumors or prostate cancers have been included until the end of 2016. From the 6914 patients included during the first five years, 98% were sampled for blood at diagnosis, 83% had paraffin-embedded and 58% had fresh frozen tissues collected. For Uppsala County, 55% of all cancer patients were included in the cohort.Conclusions: Close collaboration between participating hospitals and universities enabled prospective, longitudinal biobanking of blood and tissues and collection of multidisciplinary clinical data from cancer patients in the U-CAN cohort. Here, we summarize the first five years of operations, present U-CAN as a highly valuable cohort that will contribute to enhanced cancer research and describe the procedures to access samples and data.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-2 av 2
Typ av publikation
tidskriftsartikel (2)
Typ av innehåll
refereegranskat (2)
Författare/redaktör
Glimelius, Bengt (2)
Lindman, Henrik (2)
Riklund, Katrine (1)
Claesson-Welsh, Lena (1)
Edqvist, Per-Henrik ... (1)
visa fler...
Pontén, Fredrik (1)
Helleday, Thomas (1)
Schwenk, Jochen M. (1)
Ahlström, Håkan (1)
Enblad, Gunilla (1)
Hultdin, Magnus (1)
Sundström, Christer (1)
Höglund, Martin (1)
Jonsson, Håkan (1)
Aaronson, Neil K. (1)
Johansson, Birgitta, ... (1)
Buffart, Laurien M. (1)
Alafuzoff, Irina (1)
Häggman, Michael (1)
Sjövall, Katarina (1)
Bill-Axelson, Anna (1)
Bergh, Anders (1)
Thellenberg Karlsson ... (1)
Westermark, Bengt (1)
Hansson, Tony (1)
Rosenquist, Richard (1)
Stenling, Roger (1)
Pingel, Ronnie, 1978 ... (1)
Åsenlöf, Pernilla, 1 ... (1)
Nordin, Karin (1)
Hesselager, Göran (1)
Hellman, Per (1)
Henriksson, Anna (1)
Igelström, Helena, 1 ... (1)
Palmqvist, Richard (1)
Ljuslinder, Ingrid (1)
Stålberg, Karin (1)
Sjöblom, Tobias (1)
Johansson, Silvia (1)
Sandin, Fredrik (1)
Melin, Beatrice (1)
Raastad, Truls (1)
Stålberg, Peter (1)
Birgisson, Helgi (1)
Berntsen, Sveinung (1)
Hellbom, Maria (1)
Brooke, Hannah L (1)
Björ, Ove (1)
Demmelmaier, Ingrid, ... (1)
visa färre...
Lärosäte
Uppsala universitet (2)
Umeå universitet (1)
Kungliga Tekniska Högskolan (1)
Linköpings universitet (1)
Lunds universitet (1)
Karolinska Institutet (1)
Språk
Engelska (2)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy